rs1130864
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000567.3(CRP):c.*224C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.273 in 491,546 control chromosomes in the GnomAD database, including 20,033 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5728 hom., cov: 32)
Exomes 𝑓: 0.28 ( 14305 hom. )
Consequence
CRP
NM_000567.3 3_prime_UTR
NM_000567.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.61
Genes affected
CRP (HGNC:2367): (C-reactive protein) The protein encoded by this gene belongs to the pentraxin family which also includes serum amyloid P component protein and pentraxin 3. Pentraxins are involved in complement activation and amplification via communication with complement initiation pattern recognition molecules, but also complement regulation via recruitment of complement regulators. The encoded protein has a calcium dependent ligand binding domain with a distinctive flattened beta-jellyroll structure. It exists in two forms as either a pentamer in circulation or as a nonsoluble monomer in tissues. It is involved in several host defense related functions based on its ability to recognize foreign pathogens and damaged cells of the host and to initiate their elimination by interacting with humoral and cellular effector systems in the blood. Consequently, the level of this protein in plasma increases greatly during acute phase response to tissue injury, infection, or other inflammatory stimuli. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.31 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRP | NM_000567.3 | c.*224C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000255030.9 | NP_000558.2 | ||
CRP | NM_001382703.1 | c.*224C>T | 3_prime_UTR_variant | Exon 3 of 3 | NP_001369632.1 | |||
CRP | NM_001329057.2 | c.*22+202C>T | intron_variant | Intron 2 of 2 | NP_001315986.1 | |||
CRP | NM_001329058.2 | c.*22+202C>T | intron_variant | Intron 3 of 3 | NP_001315987.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39704AN: 151964Hom.: 5718 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
39704
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.279 AC: 94593AN: 339462Hom.: 14305 Cov.: 4 AF XY: 0.279 AC XY: 48629AN XY: 173992 show subpopulations
GnomAD4 exome
AF:
AC:
94593
AN:
339462
Hom.:
Cov.:
4
AF XY:
AC XY:
48629
AN XY:
173992
Gnomad4 AFR exome
AF:
AC:
1653
AN:
10774
Gnomad4 AMR exome
AF:
AC:
4028
AN:
11902
Gnomad4 ASJ exome
AF:
AC:
3220
AN:
11070
Gnomad4 EAS exome
AF:
AC:
1788
AN:
26912
Gnomad4 SAS exome
AF:
AC:
3686
AN:
16844
Gnomad4 FIN exome
AF:
AC:
8005
AN:
23096
Gnomad4 NFE exome
AF:
AC:
66039
AN:
216356
Gnomad4 Remaining exome
AF:
AC:
5777
AN:
20934
Heterozygous variant carriers
0
3125
6250
9374
12499
15624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.261 AC: 39754AN: 152084Hom.: 5728 Cov.: 32 AF XY: 0.263 AC XY: 19572AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
39754
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
19572
AN XY:
74324
Gnomad4 AFR
AF:
AC:
0.156369
AN:
0.156369
Gnomad4 AMR
AF:
AC:
0.307763
AN:
0.307763
Gnomad4 ASJ
AF:
AC:
0.306052
AN:
0.306052
Gnomad4 EAS
AF:
AC:
0.0602782
AN:
0.0602782
Gnomad4 SAS
AF:
AC:
0.242022
AN:
0.242022
Gnomad4 FIN
AF:
AC:
0.355178
AN:
0.355178
Gnomad4 NFE
AF:
AC:
0.313583
AN:
0.313583
Gnomad4 OTH
AF:
AC:
0.270873
AN:
0.270873
Heterozygous variant carriers
0
1467
2934
4401
5868
7335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
588
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at